David Bourne
President, Bourne Strategic
Helping Life Science Tools & IVD Companies Turn Strategy into Revenue
Whether you’re seeking market clarity, growth, or partnerships, I bring structured thinking and seasoned execution to help you reach your goals.
Who I Work With?
Life science tools and IVD companies—from startup to scale-up.
What I Bring?
A unique mix of technical insight and commercial leadership.
I started my career in R&D, then progressed through sales and marketing, business unit leadership, global BD, strategic planning, and corporate development. I’ve led each of these functions and bring a 360° view of growth drivers across the life sciences value chain.
Core Expertise
- Business Development Strategy & Execution
- Commercialization Planning
- Go-to-Market Strategy & Execution
- Strategic Partnerships
- Product-Market Fit & Market Entry
- M&A (Buy- and Sell-side)
Career Highlights
Tm Bioscience → Luminex → DiaSorin
- Joined startup MDx company Tm Bioscience in 2006
- Acquired by Luminex in 2007
- Helped scale Luminex 10x to ~$500M in annual revenue
- Served as VP of BD & Strategic Planning
- Led and supported multiple acquisitions and integrations
- Luminex acquired by DiaSorin in 2021
Bourne Strategic founded in 2023
Why Clients Work With Me
“David sees the big picture—strategy, operations, and execution—and knows how to turn it into a growth plan that works.”
– CEO, Molecular Diagnostic Company
With experience across the full lifecycle of IVD and life science tools businesses, I help clients navigate uncertainty, focus their strategy, and build lasting commercial momentum.
Market Segment Experience
IVD & Life Science Tools
19
years
Pharma
5
years
Deal Negotiation Experience
Deals Signed
>100
Combined Deal Value
>$600M
Functional Area Leadership Experience
Global Business Development & Licensing
Alliance Management
Business Leader (GM)
M&A
Corporate Development
Strategic Planning
Sales & Marketing
Research & Development
Former Employers
